Published in Hum Vaccin Immunother on December 02, 2015
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis (2010) 8.37
Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med (2007) 6.54
KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant (2009) 6.43
Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med (2009) 5.47
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis (2011) 5.31
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant (2009) 5.10
23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet (2000) 4.23
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (2012) 3.26
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91
Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med (2002) 2.73
Influenza vaccines for the future. N Engl J Med (2010) 2.54
Pneumococcal vaccines WHO position paper--2012. Wkly Epidemiol Rec (2012) 2.51
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet (2011) 2.50
Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis (2007) 2.45
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Intern Med (1991) 2.42
A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med (2010) 2.30
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant (2011) 2.28
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. J Infect Dis (2008) 2.27
Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2013) 2.20
Rotavirus vaccines. WHO position paper – January 2013. Wkly Epidemiol Rec (2013) 2.15
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis (2012) 2.08
Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant (2015) 2.03
Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2010) 2.00
High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients. Am J Transplant (2015) 1.99
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis (2010) 1.98
Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant (2007) 1.83
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis (2014) 1.81
Development of a live attenuated varicella vaccine. Biken J (1975) 1.74
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.67
A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J Infect Dis (1999) 1.62
Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis (2011) 1.49
Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant (2004) 1.48
Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients. Am J Transplant (2007) 1.47
Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients. Pediatr Transplant (2005) 1.47
Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. Vaccine (2008) 1.45
Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine (2011) 1.44
Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant (2009) 1.42
Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells. J Infect Dis (2012) 1.42
Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant (2009) 1.42
Measles - United States, January 1-May 23, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.40
Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine (1999) 1.37
A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation (2010) 1.35
Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29
Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol (1994) 1.26
Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Wkly Epidemiol Rec (2014) 1.26
Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis (2009) 1.22
Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant (2009) 1.20
A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults. J Infect Dis (2010) 1.10
Worldwide experience with the Oka-strain live varicella vaccine. Postgrad Med J (1985) 1.10
Reimmunization after bone marrow transplantation--current recommendations and perspectives. Braz J Med Biol Res (2003) 1.08
Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant (2000) 1.07
Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood (2002) 1.04
Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J Infect Dis (2012) 1.03
Varicella zoster virus (VZV) in solid organ transplant recipients. Am J Transplant (2009) 1.02
Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. J Infect Dis (1997) 1.01
Varicella in children with renal transplants. J Pediatr (1981) 1.00
Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera. Expert Rev Vaccines (2008) 1.00
A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis (2007) 1.00
Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant (2008) 1.00
Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics (1997) 0.99
Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis (1989) 0.98
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults. J Infect Dis (2013) 0.98
Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant (2011) 0.98
Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood (1996) 0.97
Vaccination in solid organ transplantation. Am J Transplant (2013) 0.96
Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant (2006) 0.96
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood (2014) 0.93
Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother (2013) 0.93
Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis (1990) 0.90
Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study. Transpl Infect Dis (2011) 0.89
Efficacy and safety of immunization for pre- and post- liver transplant children. Transplantation (2002) 0.89
Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance. Am J Transplant (2007) 0.88
Polio vaccines: WHO position paper, January 2014--recommendations. Vaccine (2014) 0.88
The detection of specific antibody formation to recall antigens after human bone marrow transplantation. Blood (1986) 0.87
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant (2011) 0.87
Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs. Bone Marrow Transplant (2010) 0.87
Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis (1999) 0.86
Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transpl (2001) 0.86
Varicella in pediatric renal transplant recipients. Pediatrics (1992) 0.85
Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation (2001) 0.85
A community-based survey of varicella-zoster virus-specific immune responses in the elderly. J Clin Virol (2012) 0.85
Live virus immunization after orthotopic liver transplantation. Pediatr Transplant (2006) 0.85
Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology (1997) 0.85
Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine. Vaccine (2013) 0.85
Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am J Med Sci (1999) 0.84
Incidence and clinical characteristics of herpes zoster after lung transplantation. J Heart Lung Transplant (2008) 0.84
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood (2006) 0.84
Response to measles-mumps-rubella vaccine in children on dialysis. Pediatr Nephrol (1992) 0.83
Experience with use of Zostavax(®) in patients with hematologic malignancy and hematopoietic cell transplant recipients. Am J Hematol (2011) 0.83
Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients. Am J Transplant (2013) 0.82
Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant (2013) 0.82
Influenza prevention and treatment in transplant recipients and immunocompromised hosts. Influenza Other Respir Viruses (2013) 0.81
Loss of antibodies to measles and varicella following solid organ transplantation in children. Pediatr Transplant (2005) 0.81
Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol (1990) 0.81
Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant (2013) 0.81
Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT). Biol Blood Marrow Transplant (2011) 0.81